6/4 2021

MCDC member receives DoD funding for Phase-2 trials of PUL-042 against COVID-19

2021-07-07T19:42:22+00:00June 4th, 2021|Success Stories|

Pulmotect, Inc., a clinical-stage biotechnology company and non-traditional Medical CBRN Defense Consortium (MCDC) member, is joining the fight against COVID-19.

3/20 2020

Coronavirus pandemic solutions sought by government; MCDC releases Request for Information

2021-07-02T20:33:39+00:00March 20th, 2020|News|

Medical CBRN Defense Consortium (MCDC) has released a Request for Information (RFI) seeking solutions to combat the novel Coronavirus (2019-nCoV) pandemic.

Go to Top